Philips announces the acquisition of CardioProlific Inc.

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease.

Philips is the leader in image guided therapy and committed to working with health care providers to improve treatment for every patient. Our seamless integrated solutions advance minimally invasive procedures by helping clinicians to decide, guide, treat and confirm the right therapy for each patient at the point of care.

Below you can view the currently available peripheral products, related technologies, and a compatibility chart with Philips Core systems.

Your list has been sent

By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.